Rosa Visits 2 - 3: A 51-year-old woman requiring additional lipid-lowering therapy

Curriculum:
Optimizing lipid-lowering therapy
Credits:
0.5 ACPE 0.5 ANCC Contract Hours 0.5 AMA PRA Category 1 Credit(s)™
Launch Date:
04-Oct-12
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

James A. Underberg, MD, MS, FACPM, FACP, FNLA

James Underberg, MD, MS, FACPM, FACP, FNLA
Clinical Assistant Professor of Medicine 
NYU Medical School 
Director, Primary Care Lipid Management Clinic
Bellevue Hospital Lipid Clinic
New York, New York

Dr. Underberg is a Clinical Assistant Professor of Medicine in the Division of General Internal Medicine at NYU Medical School and Director, Primary Care Lipid Management Clinic, Bellevue Hospital. He is also a member of the executive committee of the Division of General Internal Medicine. His clinical focus is Preventive Cardiovascular Medicine. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension, a fellow of the American College of Preventive Medicine, a fellow of the Society for Vascular Medicine & Biology, a Diplomate of the American Board of Clinical Lipidology, and a North American Menopause Society Certified Menopause Practitioner.
 
Dr. Underberg is the founder and President of the New York Preventive Cardiovascular Society and a member of the Board of Directors of the Northeast Chapter of the National Lipid Association. In addition, he is on the editorial board of the Journal of Clinical Lipidology.
 
He graduated from Yale University with a BS and MS and from the University of Pennsylvania Medical School. His internship and residency were completed at Bellevue Hospital Medical Center. He is currently involved in several clinical trials in the areas of hypertension, lipids, diabetes and cardiovascular disease. Dr. Underberg's Clinical Practice was recently awarded recognition by the American Heart Association/American Stroke Association and the National Committee for Quality Assurance Heart-Stroke Recognition Program and the American Diabetes Association Diabetes Prevention Program. He sees patients both in his private referral practice and in the Bellevue Hospital Lipid Clinic.

Lynne Braun, PhD, CNP, FAHA, FNLA

Lynne Braun, PhD, CNP, FAHA, FNLA
Professor of Nursing and Nurse Practitioner
Rush University Medical Center
Chicago, IL

Dr. Lynne Braun is a nurse practitioner in the Rush Heart and Vascular Institute, focusing on preventive cardiology and women and heart disease.  She is also a Professor in the Department of Adult Health and Gerontological Nursing in the Rush College of Nursing.  She completed a PhD in Nursing Science at the University of Illinois at Chicago in 1990, and a post-masters certificate as an Adult Nurse Practitioner from Rush University in 1997.  She has been on faculty and has held a practice position at Rush University Medical Center since 1980.  Her clinical and research interests include cardiovascular risk reduction, exercise, hyperlipidemia, and hypertension management.  She served as co-investigator for 3 research grants funded by the National Institutes of Health, currently, a study entitled, "Reducing Health Disparity in African American Women: Adherence to Physical Activity."  She is Past President of the Preventive Cardiovascular Nurses Association. 
 Dr. Braun has been an active volunteer for the American Heart Association since 1980 in numerous capacities.  Most recently, she serves on the Board of Directors of the American Heart Association of Metropolitan Chicago, Medical Leadership Committee for Chicago's Go Red Luncheon, Illinois Advocacy Committee, and is Chairperson of the Council on Cardiovascular Nursing.  Dr. Braun is regular speaker at the AHA Scientific Sessions on topics related to cardiovascular disease prevention.  She is a co-author of three AHA/ACC Scientific Statements, the AHA/ACC statement on Performance Measures for the Primary Prevention of Cardiovascular Disease, and 2 AHA clinical practice guidelines. 
 
Dr. Braun is an elected Fellow of the American Academy of Nursing, the American Heart Association, the Institute of Medicine of Chicago, the National Lipid Association, and the Preventive Cardiovascular Nurses Association. 

David T. Nash, MD, MBA, FNLA

David T. Nash, MD, MBA, FNLA*
Syracuse Preventive Cardiology
Syracuse, NY

David T. Nash, MD, FNLA, earned his bachelor's and medical degrees from New York University. He most recently served as Clinical Professor of Medicine at Upstate Medical Center in Syracuse, New York. Dr. Nash has served as a manuscript reviewer for the Journal of the Medical Association, Annals of Internal Medicine, American Journal of Cardiology, Journal of the American College of Cardiology, Postgraduate Medicine, and Geriatrics. He is a Diplomate of the American Board of Clinical Lipidology and certified by American Board of Internal Medicine. Dr. Nash is a Fellow of the American College of Physicians, American College of Cardiology, American College of Nutrition, the Council on Arteriosclerosis (American Hear Association), and the Council on Epidemiology (American Heart Association).
1. Demonstrate improvement in getting patients to lipid goals aligned with performance indicators 
2. Implement strategies for the entire patient care team to improve patient adherence to lipid-modifying therapies 
3. Identify the frequency and secondary causes of statin intolerance and treatment options for statin-intolerant patients
4. Identify contributing factors and implications of nonadherence to lipid-lowering therapies in light of recent findings, and with a focus on recognizing cultural disparities
5. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families